Cargando…

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy

Diabetic nephropathy is a leading cause of end-stage renal disease worldwide. The multipronged drug approach targeting blood pressure and serum levels of glucose, insulin, and lipids fails to fully prevent the onset and progression of diabetic nephropathy. Therefore, a new therapeutic target to comb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamahara, Kosuke, Yasuda, Mako, Kume, Shinji, Koya, Daisuke, Maegawa, Hiroshi, Uzu, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877624/ https://www.ncbi.nlm.nih.gov/pubmed/24455746 http://dx.doi.org/10.1155/2013/193757

Ejemplares similares

Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2014)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
por: Tanaka, Yuki, et al.
Publicado: (2012)

Roles of mTOR in Diabetic Kidney Disease
por: Yasuda-Yamahara, Mako, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2020)

Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2015)

Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy
por: Araki, Hisazumi, et al.
Publicado: (2013)

Role of dietary amino acid balance in diet restriction‐mediated lifespan extension, renoprotection, and muscle weakness in aged mice
por: Yoshida, Shohei, et al.
Publicado: (2018)

Nutrient Sensing, Autophagy, and Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2012)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Improvement in Decline Rate of Estimated Glomerular Filtration Rate after Febuxostat Treatment in a Fabry Disease Patient with Enzyme Replacement Therapy-resistant Proteinuria
por: Kume, Shinji, et al.
Publicado: (2022)

Ketone bodies: A double‐edged sword for mammalian life span
por: Tomita, Issei, et al.
Publicado: (2023)

Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
por: Kitada, Munehiro, et al.
Publicado: (2012)

Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
por: Araki, Shin-ichi, et al.
Publicado: (2010)

Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation
por: Takagi, Ayano, et al.
Publicado: (2016)

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
por: Maeda, Shiro, et al.
Publicado: (2011)

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
por: Kume, Shinji, et al.
Publicado: (2012)

Predictive Properties of Plasma Amino Acid Profile for Cardiovascular Disease in Patients with Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2014)

Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
por: Kitada, Munehiro, et al.
Publicado: (2011)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

Oral glucose‐stimulated serum C‐peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment
por: Araki, Hisazumi, et al.
Publicado: (2013)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
por: Kume, Shinji, et al.
Publicado: (2019)

Lipid mediators in diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2014)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013)

Effects of blood pressure and the renin‐angiotensin system on platelet activation in type 2 diabetes
por: Uzu, Takashi, et al.
Publicado: (2010)

The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy
por: Szostak, Joanna, et al.
Publicado: (2023)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

Rodent models of diabetic nephropathy: their utility and limitations
por: Kitada, Munehiro, et al.
Publicado: (2016)

Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice
por: Komeno, Masahiro, et al.
Publicado: (2021)

The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
por: Tang, Jian, et al.
Publicado: (2019)

Pathogenesis of diabetic nephropathy
por: Cao, Zemin, et al.
Publicado: (2011)

AIF1L regulates actomyosin contractility and filopodial extensions in human podocytes
por: Yasuda-Yamahara, Mako, et al.
Publicado: (2018)

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
por: Yang, Xu, et al.
Publicado: (2011)

Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients
por: Araki, Shin-ichi, et al.
Publicado: (2009)

Arterial stiffness and renal impairment in non‐proteinuric type 2 diabetic patients
por: Nakao, Keiko, et al.
Publicado: (2011)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2016)

Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dkbl0ra7mi2cbal6jufnm3t50p